Michael Schmidt
Stock Analyst at Guggenheim
(4.92)
# 50
Out of 5,042 analysts
120
Total ratings
72.63%
Success rate
34.38%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Michael Schmidt
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| GMAB Genmab | Upgrades: Buy | $43 | $29.89 | +43.86% | 3 | Sep 23, 2025 | |
| INCY Incyte | Reiterates: Neutral | n/a | $91.28 | - | 6 | Sep 19, 2025 | |
| IMNM Immunome | Reiterates: Buy | $25 | $15.69 | +59.34% | 3 | Aug 25, 2025 | |
| MRSN Mersana Therapeutics | Maintains: Buy | $125 → $30 | $9.78 | +206.75% | 4 | Aug 14, 2025 | |
| ADCT ADC Therapeutics | Reiterates: Buy | $10 | $4.09 | +144.50% | 6 | Aug 13, 2025 | |
| ORIC ORIC Pharmaceuticals | Reiterates: Buy | $18 | $13.10 | +37.40% | 6 | Aug 13, 2025 | |
| CMPX Compass Therapeutics | Maintains: Buy | $10 → $12 | $3.97 | +202.27% | 5 | Aug 12, 2025 | |
| ONC BeOne Medicines AG | Maintains: Buy | $350 → $365 | $310.81 | +17.44% | 4 | Aug 7, 2025 | |
| ARVN Arvinas | Maintains: Buy | $16 → $15 | $9.21 | +62.87% | 6 | Aug 7, 2025 | |
| TNGX Tango Therapeutics | Maintains: Buy | $8 → $10 | $7.50 | +33.42% | 1 | Aug 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $17 | $15.13 | +12.36% | 1 | Jul 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $80 | $54.48 | +46.84% | 4 | Jun 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $45 | $18.59 | +142.07% | 2 | Jun 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $40 → $15 | $18.97 | -20.93% | 1 | May 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $52 | $58.56 | -11.20% | 1 | May 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $30 → $10 | $6.86 | +45.77% | 1 | May 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $32 | $13.53 | +136.51% | 3 | May 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $12 → $8 | $19.20 | -58.33% | 2 | Apr 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $109 | $94.88 | +14.88% | 5 | Mar 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $3 → $1.75 | $0.06 | +2,604.79% | 3 | Mar 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $13 → $14 | $7.95 | +76.10% | 3 | Mar 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $31.86 | - | 1 | Mar 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $42 | $38.72 | +8.47% | 10 | Feb 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | n/a | $0.58 | - | 1 | Jan 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $20 | $5.10 | +292.16% | 1 | Dec 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $12 → $8 | $1.71 | +367.84% | 3 | Nov 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $33.18 | - | 3 | Oct 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $7 | $0.89 | +686.52% | 4 | Sep 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $6.00 | - | 2 | May 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $6.04 | - | 2 | Mar 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $1.20 | - | 1 | Jan 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $40 → $34 | $13.21 | +157.48% | 4 | Nov 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $25 | $2.38 | +950.42% | 1 | Aug 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $30 | $11.14 | +169.30% | 1 | Jul 19, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $26 | $5.76 | +351.39% | 1 | May 18, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $3.48 | - | 2 | Apr 28, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $80 | $43.33 | +84.63% | 5 | Feb 15, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $8.95 | - | 6 | Jan 17, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $4 → $5.5 | $4.36 | +26.15% | 2 | Nov 7, 2017 |
Genmab
Sep 23, 2025
Upgrades: Buy
Price Target: $43
Current: $29.89
Upside: +43.86%
Incyte
Sep 19, 2025
Reiterates: Neutral
Price Target: n/a
Current: $91.28
Upside: -
Immunome
Aug 25, 2025
Reiterates: Buy
Price Target: $25
Current: $15.69
Upside: +59.34%
Mersana Therapeutics
Aug 14, 2025
Maintains: Buy
Price Target: $125 → $30
Current: $9.78
Upside: +206.75%
ADC Therapeutics
Aug 13, 2025
Reiterates: Buy
Price Target: $10
Current: $4.09
Upside: +144.50%
ORIC Pharmaceuticals
Aug 13, 2025
Reiterates: Buy
Price Target: $18
Current: $13.10
Upside: +37.40%
Compass Therapeutics
Aug 12, 2025
Maintains: Buy
Price Target: $10 → $12
Current: $3.97
Upside: +202.27%
BeOne Medicines AG
Aug 7, 2025
Maintains: Buy
Price Target: $350 → $365
Current: $310.81
Upside: +17.44%
Arvinas
Aug 7, 2025
Maintains: Buy
Price Target: $16 → $15
Current: $9.21
Upside: +62.87%
Tango Therapeutics
Aug 6, 2025
Maintains: Buy
Price Target: $8 → $10
Current: $7.50
Upside: +33.42%
Jul 8, 2025
Reiterates: Buy
Price Target: $17
Current: $15.13
Upside: +12.36%
Jun 25, 2025
Reiterates: Buy
Price Target: $80
Current: $54.48
Upside: +46.84%
Jun 24, 2025
Reiterates: Buy
Price Target: $45
Current: $18.59
Upside: +142.07%
May 23, 2025
Maintains: Buy
Price Target: $40 → $15
Current: $18.97
Upside: -20.93%
May 12, 2025
Reiterates: Buy
Price Target: $52
Current: $58.56
Upside: -11.20%
May 7, 2025
Maintains: Buy
Price Target: $30 → $10
Current: $6.86
Upside: +45.77%
May 6, 2025
Reiterates: Buy
Price Target: $32
Current: $13.53
Upside: +136.51%
Apr 4, 2025
Maintains: Buy
Price Target: $12 → $8
Current: $19.20
Upside: -58.33%
Mar 28, 2025
Reiterates: Buy
Price Target: $109
Current: $94.88
Upside: +14.88%
Mar 26, 2025
Maintains: Buy
Price Target: $3 → $1.75
Current: $0.06
Upside: +2,604.79%
Mar 24, 2025
Maintains: Buy
Price Target: $13 → $14
Current: $7.95
Upside: +76.10%
Mar 12, 2025
Reiterates: Neutral
Price Target: n/a
Current: $31.86
Upside: -
Feb 12, 2025
Reiterates: Buy
Price Target: $42
Current: $38.72
Upside: +8.47%
Jan 22, 2025
Reiterates: Buy
Price Target: n/a
Current: $0.58
Upside: -
Dec 6, 2024
Reiterates: Buy
Price Target: $20
Current: $5.10
Upside: +292.16%
Nov 15, 2024
Maintains: Buy
Price Target: $12 → $8
Current: $1.71
Upside: +367.84%
Oct 7, 2024
Downgrades: Neutral
Price Target: n/a
Current: $33.18
Upside: -
Sep 30, 2024
Upgrades: Buy
Price Target: $7
Current: $0.89
Upside: +686.52%
May 15, 2024
Downgrades: Neutral
Price Target: n/a
Current: $6.00
Upside: -
Mar 14, 2024
Downgrades: Neutral
Price Target: n/a
Current: $6.04
Upside: -
Jan 5, 2024
Downgrades: Neutral
Price Target: n/a
Current: $1.20
Upside: -
Nov 8, 2023
Maintains: Buy
Price Target: $40 → $34
Current: $13.21
Upside: +157.48%
Aug 10, 2021
Initiates: Buy
Price Target: $25
Current: $2.38
Upside: +950.42%
Jul 19, 2021
Initiates: Buy
Price Target: $30
Current: $11.14
Upside: +169.30%
May 18, 2021
Initiates: Buy
Price Target: $26
Current: $5.76
Upside: +351.39%
Apr 28, 2021
Downgrades: Neutral
Price Target: n/a
Current: $3.48
Upside: -
Feb 15, 2019
Upgrades: Outperform
Price Target: $80
Current: $43.33
Upside: +84.63%
Jan 17, 2019
Initiates: Outperform
Price Target: n/a
Current: $8.95
Upside: -
Nov 7, 2017
Maintains: Market Perform
Price Target: $4 → $5.5
Current: $4.36
Upside: +26.15%